Carsgen Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Magnifying glass resting on computer

Regulatory

29 November 2023

Investors brush off Car-T scare

But the FDA’s investigation looks like worse news for autoimmune disease than oncology.

Regulatory

4 October 2023

The second phase 3 Claudin18.2 asset belongs to Transcenta

Deals

21 August 2023

Moderna gets into Claudin18.2

Subscribe to Carsgen Therapeutics